Selection and characterization of Anticalins targeting human prostate-specific membrane antigen (PSMA)

Protein Engineering, Design and Selection

Volumn 29, Issue 3, 2015, Pages 105-115

  Barinka, Cyril ^a   Ptacek, Jakub ^a,b   Richter, Antonia ^c   Novakova, Zora ^a   Morath, Volker ^c   Skerra, Arne ^c  

^a INSTITUTE OF MATHEMATICS   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Anticalin; glutamate carboxypeptidase II; lipocalin; non immunoglobulin scaffold; prostate carcinoma

Indexed keywords

ANTIGENS; BINS; CELL CULTURE; DIAGNOSIS; DISEASE CONTROL; DISSOCIATION; ESCHERICHIA COLI; MEDICAL APPLICATIONS; PROTEINS; TUMORS; UROLOGY;

ANTICALIN; BINDING CHARACTERISTICS; BIOMEDICAL APPLICATIONS; CARBOXYPEPTIDASE; FLOW-CYTOMETRIC ANALYSIS; IMMUNOFLUORESCENCE MICROSCOPY; LIPOCALIN; PROSTATE CARCINOMA;

SCAFFOLDS (BIOLOGY);

ANTICALIN; MOLECULAR SCAFFOLD; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PROSTATE SPECIFIC MEMBRANE ANTIGEN; UNCLASSIFIED DRUG; GLUTAMATE CARBOXYPEPTIDASE II; GLUTAMATE CARBOXYPEPTIDASE II, HUMAN; LIPOCALIN; MEMBRANE ANTIGEN;

ARTICLE; BINDING AFFINITY; CELL SELECTION; CONTROLLED STUDY; DISSOCIATION CONSTANT; DRUG TARGETING; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FLOW CYTOMETRY; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; MALE; PEPTIDE LIBRARY; PRIORITY JOURNAL; PROSTATE CARCINOMA; RANDOMIZED CONTROLLED TRIAL; SURFACE PROPERTY; TUMOR CELL LINE; AMINO ACID SEQUENCE; CHEMISTRY; GENETICS; METABOLISM; MOLECULAR GENETICS; MOLECULAR MODEL; MUTATION; PROTEIN ENGINEERING; PROTEIN TERTIARY STRUCTURE;

AMINO ACID SEQUENCE; ANTIGENS, SURFACE; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLUTAMATE CARBOXYPEPTIDASE II; HUMANS; LIPOCALINS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN ENGINEERING; PROTEIN STRUCTURE, TERTIARY;

EID: 84960121081     PISSN: 17410126     EISSN: 17410134     Source Type: Journal    
DOI: 10.1093/protein/gzv065     Document Type: Article

References (35)

1. Afshar-Oromieh, A., Avtzi, E., Giesel, F.L., et al. (2014) Eur. J. Nucl. Med. Mol. Imaging, 42, 197-209.
2. Barinka, C., Rinnova, M., Sacha, P., Rojas, C., Majer, P., Slusher, B.S. and Konvalinka, J. (2002) J. Neurochem., 80, 477-487.
3. Barinka, C., Mlcochova, P., Sacha, P., Hilgert, I., Majer, P., Slusher, B.S., Horejsi, V. and Konvalinka, J. (2004a) Eur. J. Biochem., 271, 2782-2790.
4. Barinka, C., Sacha, P., Sklenar, J., Man, P., Bezouska, K., Slusher, B.S. and Konvalinka, J. (2004b) Protein Sci., 13, 1627-1635.
5. Barinka, C., Rojas, C., Slusher, B. and Pomper, M. (2012) Curr. Med. Chem., 19, 856-870.
6. Barrett, J.A., Coleman, R.E., Goldsmith, S.J., et al. (2013) J. Nucl. Med., 54, 380-387.
7. Binder, U., Matschiner, G., Theobald, I. and Skerra, A. (2010) J. Mol. Biol., 400, 783-802.
8. Chang, S.S., Reuter, V.E., Heston, W.D., Bander, N.H., Grauer, L.S. and Gaudin, P.B. (1999) Cancer Res., 59, 3192-3198.
9. Cho, S.Y., Gage, K.L., Mease, R.C., et al. (2012) J. Nucl. Med., 53, 1883-1891.
10. David, K.A., Milowsky, M.I., Kostakoglu, L., Vallabhajosula, S., Goldsmith, S.J., Nanus, D.M. and Bander, N.H. (2006) Clin. Genitourin Cancer, 4, 249-256.
11. De Crescenzo, G., Woodward, L. and Srinivasan, B. (2008) J. Mol. Recognit., 21, 256-266.
12. Ellis, R.J., Kaminsky, D.A., Zhou, E.H., Fu, P., Chen, W.D., Brelin, A., Faulhaber, P.F. and Bodner, D. (2011) Int. J. Radiat. Oncol. Biol. Phys., 81, 29-34.
13. Elsässer-Beile, U., Wolf, P., Gierschner, D., Bühler, P., Schultze-Seemann, W. and Wetterauer, U. (2006) Prostate, 66, 1359-1370.
14. Ferraris, D.V., Shukla, K. and Tsukamoto, T. (2012) Curr. Med. Chem., 19, 1282-1294.
15. Foss, C.A., Mease, R.C., Cho, S.Y., Kim, H.J. and Pomper, M.G. (2012) Curr. Med. Chem., 19, 1346-1359.
16. Gebauer, M. and Skerra, A. (2012) Methods Enzymol., 503, 157-188.
17. Gebauer, M., Schiefner, A., Matschiner, G. and Skerra, A. (2013) J. Mol. Biol., 425, 780-802.
18. Haffner, M.C., Kronberger, I.E., Ross, J.S., et al. (2009) Hum. Pathol., 40, 1754-1761.
19. Holmes, E.H., Greene, T.G., Tino, W.T., Boynton, A.L., Aldape, H.C., Misrock, S. L. and Murphy, G.P. (1996) Prostate Suppl., 7, 25-29.
20. Huber, F., Montani, M., Sulser, T., et al. (2015) Br. J. Cancer, 112, 140-148.
21. Jose, J., Kramer, J., Klauser, T., Pohlner, J. and Meyer, T.F. (1996) Gene, 178, 107-110.
22. Kim, H.J., Eichinger, A. and Skerra, A. (2009) J. Am. Chem. Soc., 131, 3565-3576.
23. Mease, R.C., Foss, C.A. and Pomper, M.G. (2013) Curr. Top. Med. Chem., 13, 951-962.
24. Mendler, C.T., Friedrich, L., Laitinen, I., Schlapschy, M., Schwaiger, M., Wester, H.J. and Skerra, A. (2015) MAbs, 7, 96-109.
25. Mross, K., Richly, H., Fischer, R., Scharr, D., Buchert, M., Stern, A., Gille, H., Audoly, L.P. and Scheulen, M.E. (2013) PLoS One, 8, e83232.
26. Myszka, D.G. (1999) J. Mol. Recognit., 12, 279-284.
27. Nedrow-Byers, J.R., Moore, A.L., Ganguly, T., Hopkins, M.R., Fulton, M.D., Benny, P.D. and Berkman, C.E. (2013) Prostate, 73, 355-362.
28. Richter, A., Eggenstein, E. and Skerra, A. (2014) FEBS Lett., 588, 213-218.
29. Samplaski, M.K., Heston, W., Elson, P., Magi-Galluzzi, C. and Hansel, D.E. (2011) Mod. Pathol., 24, 1521-1529.
30. Schiefner, A. and Skerra, A. (2015) Acc. Chem. Res., 48, 976-985.
31. Schmidt, T.G. and Skerra, A. (2007) Nat. Protoc., 2, 1528-1535.
32. Tykvart, J., Sacha, P., Barinka, C., Knedlik, T., Starkova, J., Lubkowski, J. and Konvalinka, J. (2012) Protein Expr. Purif., 82, 106-115.
33. Vallabhajosula, S., Kuji, I., Hamacher, K.A., et al. (2005) J. Nucl. Med., 46, 634-641.
34. Wang, W., Tavora, F., Sharma, R., Eisenberger, M. and Netto, G.J. (2009) Urol. Oncol., 27, 525-528.
35. Wright, G.L., Jr., Haley, C., Beckett, M.L. and Schellhammer, P.F. (1995) Urol. Oncol., 1, 18-28.